上海口腔医学 ›› 2026, Vol. 35 ›› Issue (5): 481-485.doi: 10.19439/j.sjos.2026.05.006

• 论著 • 上一篇    下一篇

重组牛碱性成纤维细胞生长因子凝胶联合减张美容缝合治疗颌面部外伤的效果评价

董建伟1, 岳鹏1, 陈文静2   

  1. 1.商洛市中心医院 口腔科,2.医疗美容科,陕西 商洛 726000
  • 收稿日期:2025-04-29 修回日期:2025-06-11 发布日期:2026-11-05
  • 通讯作者: 陈文静,E-mail: 374102763@qq.com
  • 作者简介:董建伟(1992—),男,硕士,E-mail: djwDoctor_6665@163.com
  • 基金资助:
    陕西省重点研发计划(2020SF-179)

Evaluation of the effect of recombinant bovine basic fibroblast growth factor gel combined with slimmer aesthetic suture in the treatment of maxillofacial trauma

Dong Jianwei1, Yue Peng1, Chen Wenjing2   

  1. 1. Department of Stomatology, 2. Department of Medical Aesthetics, Shangluo Central Hospital. Shangluo 726000, Shaanxi Province, China
  • Received:2025-04-29 Revised:2025-06-11 Published:2026-11-05

摘要: 目的: 评价重组牛碱性成纤维细胞生长因子(recombinant bovine basic fibroblast growth factor,rb-bFGF)联合减张美容缝合治疗颌面部外伤的效果。方法: 选择2020年6月—2024年6月商洛市中心医院收治的98例颌面部外伤患者,采用随机数字表法分为对照组和试验组,每组49例。对照组采用减张美容缝合,试验组采用rb-bFGF联合减张美容缝合。比较两组临床疗效、创面愈合情况、炎症因子[肿瘤坏死因子α(tumor necrosis factor-alpha,TNF-α)、白细胞介素6(interleukin-6,IL-6)和表皮生长因子(epidermal growth factor,EGF)]、瘢痕情况[双向瘢痕评分量表(patient and observer scar assessment scale,POSAS)、温哥华评分量表(Vancouver scar scale,VSS)]和并发症发生情况。结果: 试验组治疗总有效率显著高于对照组。试验组表皮生长时间、创面愈合时间、瘢痕长度显著短于对照组。术后7、14天,试验组TNF-α、IL-6水平显著低于对照组,EGF水平显著高于对照组。术后3、6个月,试验组POSAS、VSS评分显著低于对照组(P<0.05)。两组并发症发生率相比无显著差异(P>0.05)。结论: rb-bFGF联合减张美容缝合治疗颌面部外伤能显著提高总有效率,加快创面愈合,减少术后瘢痕,降低炎症因子水平,改善瘢痕评分,并发症发生率无显著增加。

关键词: 颌面部外伤, 重组牛碱性成纤维细胞生长因子, 减张美容缝合术, 临床疗效, 创面愈合

Abstract: PURPOSE: To evaluate the effect of recombinant bovine basic fibroblast growth factor(rb-bFGF) combined with slim-reducing aesthetic suture in the treatment of maxillofacial trauma. METHODS: A total of 98 patients with maxillofacial trauma admitted to Shangluo Central Hospital from June 2020 to June 2024 were selected and divided into the control group and the experimental group by the random number table method, with 49 cases in each group. The control group was treated with slim-reducing aesthetic suture, while the experimental group was treated with rb-bFGF combined with slim-reducing aesthetic suture. The clinical efficacy, wound healing, inflammatory factors [tumor necrosis factor-α(TNF-α), interleukin-6 (IL-6) and epidermal growth factor (EGF)], scar conditions [Patient And Observer Scar Assessment Scale (POSAS), Vancouver Scar Scale (VSS)] and incidence of complications were compared between the two groups. RESULTS: The total efficacy rate in the experimental group was significantly higher than that in the control group. The epidermal growth time, wound healing time and postoperative scar length were all significantly shorter than those in the experimental group. At 7 and 14 days after operation, the levels of TNF-α and IL-6 in the experimental group were significantly lower than those in the control group at different time points, and the levels of EGF were significantly higher than those in the control group. Three and six months after operation, POSAS and VSS scores were significantly lower in the experimental group(P<0.05). There was no significant difference in the rate of complications between the two groups (P>0.05). CONCLUSIONS: rb-bFGF combined with slim-reducing aesthetic suture can significantly improve the total effective rate of treatment for maxillofacial trauma, accelerates wound healing, reduces postoperative scarring, decreases inflammatory factor levels, and improves scar scores without increasing the incidence of complications in the treatment of maxillofacial trauma.

Key words: Maxillofacial trauma, Recombinant bovine basic fibroblast growth factor, Tension-reducing cosmetic suture, Clinical efficacy, Wound healing

中图分类号: